Stay updated on Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page.

Latest updates to the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page
- ChecktodayChange DetectedThe page footer now shows Revision: v3.7.0, replacing the previous Revision: v3.6.6.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe revision tag on the page changed from v3.6.5 to v3.6.6. This indicates a new release of the page, with metadata updated but no substantive changes to study information or layout.SummaryDifference0.0%

- Check21 days agoChange DetectedA funding attribution for 2023 U.S. NIH Grant/Contract was added to the CTIS registry line of the study record, updating the funding source information associated with NCT03485209. This reflects an additional grant/contract year linked to the study.SummaryDifference0.0%

- Check36 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5 on the ClinicalTrials.gov study page, indicating a minor backend/page metadata update rather than a change to visible content.SummaryDifference0.0%

- Check50 days agoChange DetectedThe study footprint expands with two new sites: Vincentius-Diakonissen-Klinken Gag Zentralapotheke in Karlsruhe, Germany and UChicago Medicine at Ingalls in Flossmoor, Illinois, bringing total locations to 175. Yale University in New Haven, CT was removed from the listed sites.SummaryDifference0.2%

- Check57 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4. This reflects a minor metadata/versioning update to the page rather than changes to the study details or content.SummaryDifference0.0%

Stay in the know with updates to Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page.